Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol | Zendy

Elizabeth A. Streeten | Zendy; Yasaman Mohtasebi | Zendy; Маниге Кониг | Zendy; Lisa Davidoff | Zendy; Kathleen A. Ryan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol

Author(s) -

Elizabeth A. Streeten,

Yasaman Mohtasebi,

Маниге Кониг,

Lisa Davidoff,

Kathleen A. Ryan

Publication year - 2017

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-3712

Subject(s) - calcitriol , hypoparathyroidism , medicine , vitamin d and neurology , renal function , parathyroid hormone , creatinine , vitamin d deficiency , urology , endocrinology , gastroenterology , calcium

Options for chronic treatment of hypoparathyroidism include calcitriol, recombinant human parathyroid hormone, and high-dose vitamin D (D2). D2 is used in a minority of patients because of fear of prolonged hypercalcemia and renal toxicity. There is a paucity of recent data about D2 use in hypoparathyroidism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research